| |
| |
|
| Insider
Information: |
Wolff Allen |
| Relationship: |
|
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
128,520 |
|
|
Indirect Shares
|
4,200 |
|
|
| Direct
Value |
$248,044 |
|
|
|
Indirect Value
|
$8,106 |
|
|
| Total
Shares |
132,720 |
|
|
| Total
Value |
$256,150 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eterna Therapeutics Inc |
ERNA |
|
2021-03-24 |
128,520 |
2021-03-24 |
4,200 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ERNA |
Eterna Therapeutics Inc |
CFO and EVP |
• – – |
2019-06-21 |
4 |
D |
$3.47 |
$489 |
D/D |
(141) |
58,429 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CFO and EVP |
• – – |
2019-07-30 |
4 |
D |
$3.18 |
$448 |
D/D |
(141) |
58,288 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CFO and EVP |
• – – |
2019-08-27 |
4 |
D |
$2.77 |
$391 |
D/D |
(141) |
58,147 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CFO and EVP |
• – – |
2018-11-20 |
4 |
D |
$2.87 |
$413 |
D/D |
(144) |
49,570 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CFO and EVP |
• – – |
2018-10-23 |
4 |
D |
$4.32 |
$626 |
D/D |
(145) |
49,714 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CFO and EVP |
• – – |
2018-12-19 |
4 |
D |
$2.00 |
$290 |
D/D |
(145) |
49,425 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CEO |
• • – |
2020-05-20 |
4 |
D |
$1.55 |
$254 |
D/D |
(164) |
147,621 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CEO |
• • – |
2020-08-25 |
4 |
D |
$2.62 |
$445 |
D/D |
(170) |
144,828 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CEO |
• • – |
2020-09-22 |
4 |
D |
$1.99 |
$338 |
D/D |
(170) |
144,658 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CEO |
• • – |
2020-11-20 |
4 |
D |
$1.88 |
$320 |
D/D |
(170) |
142,035 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CEO |
• • – |
2020-12-19 |
4 |
D |
$2.17 |
$369 |
D/D |
(170) |
141,865 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CFO and EVP |
• – – |
2019-01-29 |
4 |
D |
$3.18 |
$544 |
D/D |
(171) |
49,254 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CFO and EVP |
• – – |
2019-02-26 |
4 |
D |
$3.42 |
$585 |
D/D |
(171) |
49,083 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CFO and EVP |
• – – |
2019-03-26 |
4 |
D |
$3.72 |
$636 |
D/D |
(171) |
58,912 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CFO and EVP |
• – – |
2019-05-21 |
4 |
D |
$2.89 |
$494 |
D/D |
(171) |
58,570 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CEO |
• • – |
2020-03-25 |
4 |
D |
$1.48 |
$306 |
D/D |
(207) |
139,371 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CEO |
• • – |
2021-02-19 |
4 |
D |
$4.81 |
$996 |
D/D |
(207) |
138,671 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CEO |
• • – |
2021-03-19 |
4 |
D |
$3.53 |
$731 |
D/D |
(207) |
138,464 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Interim CEO |
• – – |
2019-10-23 |
4 |
D |
$2.88 |
$694 |
D/D |
(241) |
57,184 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Interim CEO |
• – – |
2019-11-20 |
4 |
D |
$2.62 |
$631 |
D/D |
(241) |
56,943 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
Interim CEO |
• – – |
2019-12-19 |
4 |
D |
$2.73 |
$661 |
D/D |
(242) |
56,701 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CEO |
• – – |
2020-01-29 |
4 |
D |
$2.43 |
$693 |
D/D |
(285) |
131,416 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CEO |
• • – |
2020-02-25 |
4 |
D |
$2.05 |
$584 |
D/D |
(285) |
137,853 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CFO and EVP |
• – – |
2016-11-15 |
4 |
A |
$7.46 |
$3,730 |
D/D |
500 |
28,210 |
0 |
- |
|
| ERNA |
Eterna Therapeutics Inc |
CFO and EVP |
• – – |
2016-11-15 |
4 |
A |
$7.47 |
$3,735 |
I/I |
500 |
2,100 |
0 |
- |
|
49 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
